NASDAQ:GCAN

Greater Cannabis (GCAN) Stock Price, News & Analysis

$0.0007
+0.00 (+16.67%)
(As of 03:50 PM ET)
Today's Range
$0.0005
$0.0007
50-Day Range
N/A
52-Week Range
$0.0003
$0.0015
Volume
3.79 million shs
Average Volume
3.47 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GCAN stock logo

About Greater Cannabis Stock (NASDAQ:GCAN)

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland.

GCAN Stock Price History

GCAN Stock News Headlines

The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
High Yielding Cannabis Strains
See More Headlines
Receive GCAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greater Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
NASDAQ:GCAN
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Aitan Zacharin (Age 41)
    Chairman, President, CEO, Acting CFO & Treasurer
    Comp: $120k
  • Motti Stenge
    Chief Operating Officer
  • Dr. Adi Aran M.D.
    Chief Scientific Advisor

GCAN Stock Analysis - Frequently Asked Questions

How have GCAN shares performed in 2024?

Greater Cannabis' stock was trading at $0.0009 on January 1st, 2024. Since then, GCAN shares have decreased by 22.2% and is now trading at $0.0007.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Greater Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Greater Cannabis investors own include Cannabix Technologies (BLOZF), Flowr (FLWPF), Trulieve Cannabis (TCNNF), Acreage (ACRGF), BioLineRx (BLRX), Camtek (CAMT), CNBX Pharmaceuticals (CNBX) and Cronos Group (CRON).

How do I buy shares of Greater Cannabis?

Shares of GCAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GCAN) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners